Lactation, drug toxicity

Flucytosine is contraindicated in patients with known hypersensitivity to the drug. Flucytosine is used cautiously in patients with bone marrow depression and with extreme caution in those with renal impairment. The drug is also used cautiously during pregnancy (Category C) and lactation. When flucytosine and amphotericin B are administered concurrently, the risk of flucytosine toxicity is increased. 

After birth the infant can be affected by toxic substances taken up by the lactating mother and excreted into the milk. Different drugs and environmental polluting chemicals have been shown to be excreted in milk. Clinically prescribed drugs normally do not reach high levels in breast milk, but there are exceptions. Especially chemicals which cannot be metabolized by the infant may occur in high levels, and thus become potentially harmful (refs. 64, 65). 

Lactic acid is an important chemical that has wide applications in food, pharmaceutical, cosmetic, and chemical industries. There are increasing interests in production of lactate esters and biodegradable polylactic acid (PLA) from lactic acid. Lactate esters are a relatively new family of solvents with specific properties. They are considered safe and are biodegradable (1). In many situations they can replace toxic solvents. Their functions vary from that of intermediates in chemical reactions to solvents in ink formulations and cleaning applications (2). PLA has been widely used in medical implants, sutures, and drug-delivery systems because of its capacity to dissolve over time (3-5). PLA also can be used in products such as plant pots, disposable diapers, and textile fabrics. 

---